The gMerckAG Deal is expected to be closed in October. Hard to imagine a call-off in light of Coury's ambitious. Mylan's R&D has been a success but its management is just so so. The timing of such a deal is so terrible demonstrating Coury's incapabilities. With such a huge debt and tightening credit market, even Mylan tightening its belt an unexpected financial hardship (inside or outside) may easily cause BK.
On the other hand, today's Upgrade to Barr shows that there is still some chance for globalization. However, Barr's management is much better than Coury.